Global 3D Bioprinting Market Outlook, 2030

The global 3D bioprinting market will reach $6.76 billion, driven by breakthroughs in tissue engineering, regenerative medicine, and drug development.

The global 3D bioprinting market is experiencing a period of explosive growth, driven by a confluence of technological advancements, increasing healthcare demands, and groundbreaking research. This dynamic field, at the intersection of biology, engineering, and materials science, is revolutionizing how we approach tissue engineering, regenerative medicine, and drug discovery. The ability to create complex, three-dimensional biological structures, from tissues and organs to personalized implants, holds immense promise for addressing critical medical needs. The market’s expansion is fueled by continuous innovations in bioprinting technologies, including extrusion-based, inkjet-based, and laser-assisted bioprinting, each offering unique capabilities for precise control over cell deposition and biomaterial fabrication. The rising prevalence of chronic diseases, organ transplantation shortages, and the increasing demand for personalized medicine are significant drivers. Moreover, the growing investments in research and development by pharmaceutical companies, academic institutions, and government organizations are accelerating the development of novel bioprinted products and therapies. The convergence of artificial intelligence, machine learning, and advanced imaging techniques is further enhancing the precision and efficiency of bioprinting processes. The development of biocompatible materials, such as hydrogels, polymers, and decellularized extracellular matrix, is crucial for creating functional and viable bioprinted tissues. The market is also witnessing a surge in collaborations and partnerships between industry players, fostering knowledge sharing and accelerating the commercialization of bioprinted products. The regulatory landscape is evolving to accommodate the unique challenges and opportunities presented by 3D bioprinting, with initiatives aimed at ensuring the safety and efficacy of bioprinted therapies. Furthermore, the increasing awareness of the potential of 3D bioprinting among healthcare professionals and patients is driving adoption and market growth. The ongoing research into bioprinting complex organs, such as the heart, liver, and kidneys, represents a significant milestone in the field, promising to transform organ transplantation and address the critical shortage of donor organs. The integration of microfluidics and organ-on-a-chip technologies with bioprinting is enabling the creation of sophisticated in vitro models for drug testing and disease modeling. The expanding applications of bioprinting in cosmetics, food, and environmental sectors are further broadening the market’s scope. The continuous advancements in bioink formulations, including the development of cell-laden bioinks with enhanced viability and functionality, are crucial for creating clinically relevant bioprinted tissues. The market is also witnessing the emergence of personalized bioprinting solutions, tailored to individual patient needs, offering the potential for more effective and targeted therapies. The increasing focus on sustainability and ethical considerations in bioprinting is driving the development of environmentally friendly materials and responsible practices. The global 3D bioprinting market is poised for continued growth, driven by relentless innovation, increasing healthcare demands, and the transformative potential of this groundbreaking technology.


Global 3D Bioprinting market will reach $6,760.5 million by 2031, growing by 19.7% annually over 2021-2031, driven by the increasing prevalence of chronic respiratory and cardiovascular disorders (CVDs) due to the aging population, the rising requirement for regenerative medicines/cancer therapeutics/stem cell solutions, the rising governments and private funding, and the technological advancements such as the development of AI and organ-on-a-chip. "Synergy" encapsulates the essence of the global 3D bioprinting market. Market trends are dictated by a synergy of scientific exploration, clinical application, and technological refinement. Market drivers, such as the pressing need for organ transplants, personalized medicine, and advanced drug testing platforms, synergize with technological innovations. The synergy of research funding, public-private partnerships, and international collaborations fosters the growth of the market. Regulatory frameworks, while still evolving, aim to synergize safety and innovation, ensuring the responsible development of bioprinted products. The synergy between material science and biology is crucial for creating biocompatible and functional bioinks. The synergy of AI and bioprinting enhances precision and automation, driving efficiency. Trade programs, including global conferences, industry alliances, and international research initiatives, synergize knowledge sharing and market expansion. The increasing synergy between academia and industry accelerates the translation of research findings into clinical applications. The synergy of microfluidics and bioprinting enables the creation of complex tissue models for drug discovery. The synergy of patient-specific data and bioprinting technologies facilitates personalized treatment strategies. The synergy of diverse disciplines, from engineering to medicine, is the cornerstone of 3D bioprinting's progress. The synergy of ethical considerations and technological advancements ensures responsible innovation. The synergy between bioprinting and regenerative medicine is revolutionizing patient care. The synergy of global research efforts is fostering the rapid advancement of bioprinting technologies. The synergy of market demands and technological capabilities is driving the exponential growth of the 3D bioprinting market. The synergy between diverse stakeholders is vital for realizing the full potential of 3D bioprinting.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample



The component segment of the 3D bioprinting market is the intricate machinery that breathes life into biological constructs. Imagine a symphony orchestra, where each instrument plays a crucial role in creating a harmonious masterpiece. Here, the bioprinters themselves are the conductors, orchestrating the deposition of bioinks with unparalleled precision. The bioinks, the very essence of life in this context, are the violins, carrying the cellular melodies that form tissues and organs. The dispensing systems, the flutes, ensure a steady and controlled flow of bioinks, while the support systems, the cellos, provide the necessary scaffolding for complex structures. The imaging systems, the trumpets, offer a clear vision of the developing constructs, ensuring accuracy and quality. The software, the piano, is the brains behind the operation, translating digital designs into tangible biological realities. The valves, the clarinets, regulate the flow and pressure, maintaining the delicate balance of the process. The crosslinking systems, the drums, solidify the bioinks, creating robust and stable structures. The bioreactors, the harps, nurture the developing tissues, providing the optimal environment for growth and maturation. Each component, from the smallest valve to the most sophisticated bioprinter, plays a vital role in the intricate dance of 3D bioprinting, contributing to the creation of life-saving therapies and groundbreaking research. The confluence of these components, working in perfect harmony, is what drives the innovation and growth of the 3D bioprinting market.


The material segment of the 3D bioprinting market is the palette from which biological masterpieces are created. Picture an artist’s studio, filled with a myriad of colors and textures, each offering unique possibilities. Here, the bioinks are the pigments, ranging from natural polymers like collagen and gelatin to synthetic hydrogels like polyethylene glycol. Collagen, the canvas of the body, provides structural support and promotes cell adhesion. Gelatin, the soft clay, offers a malleable and biocompatible matrix. Alginate, the seaweed silk, forms stable and porous structures. Hyaluronic acid, the fountain of youth, hydrates and rejuvenates tissues. Polycaprolactone, the durable plastic, creates long-lasting scaffolds. Decellularized extracellular matrix, the ghost tissue, provides a natural and complex environment for cell growth. Nanomaterials, the microscopic brushstrokes, enhance the mechanical and biological properties of bioinks. Growth factors, the biological paintbrushes, stimulate cell proliferation and differentiation. These materials, each with its unique properties and characteristics, are carefully selected and combined to create bioinks that mimic the natural environment of tissues and organs. The ongoing research into novel biomaterials, including smart polymers and self-healing hydrogels, is expanding the possibilities of 3D bioprinting. The development of personalized bioinks, tailored to individual patient needs, is further enhancing the efficacy of bioprinted therapies. The choice of materials is crucial for creating functional and viable bioprinted constructs, driving the innovation and growth of the 3D bioprinting market.

The technology segment of the 3D bioprinting market is the engine that drives its innovation and progress. Imagine a futuristic laboratory, filled with cutting-edge machines and sophisticated software. Here, extrusion-based bioprinting, the workhorse of the field, deposits bioinks layer by layer, creating complex structures with high precision. Inkjet-based bioprinting, the nimble artist, sprays droplets of bioinks, forming intricate patterns with high speed. Laser-assisted bioprinting, the precise sculptor, uses lasers to deposit cells with pinpoint accuracy. Stereolithography, the light architect, uses light to solidify bioinks, creating complex three-dimensional structures. Microfluidics, the miniature engineer, controls the flow of fluids and cells, creating intricate tissue models. Organ-on-a-chip technology, the miniature organ, mimics the functions of human organs, enabling drug testing and disease modeling. Artificial intelligence, the intelligent assistant, analyzes data and optimizes bioprinting processes. Machine learning, the adaptive learner, improves the accuracy and efficiency of bioprinting. Advanced imaging techniques, the clear vision, provide real-time monitoring of bioprinted constructs. These technologies, each with its unique capabilities and applications, are constantly evolving, driving the innovation and growth of the 3D bioprinting market. The integration of these technologies is further enhancing the precision, efficiency, and scalability of bioprinting processes.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant



The application segment of the 3D bioprinting market is a vast, ever-expanding canvas where scientific dreams are painted into tangible realities. Imagine a bustling, futuristic atelier, where the tools of creation are not brushes and paints, but bioinks and bioprinters. Here, tissue engineering and regenerative medicine take center stage, crafting replacement tissues and organs to mend broken bodies and extend lives. Picture a heart, meticulously printed layer by layer, beating with the promise of a second chance. Or a kidney, sculpted with cellular precision, filtering life-sustaining fluids. Drug discovery and development utilize bioprinted tissues as miniature human models, allowing researchers to test new therapies with unprecedented accuracy and speed. Envision a lab where bioprinted tumor tissues respond to experimental drugs, revealing their efficacy and potential side effects before human trials. Personalized medicine leverages bioprinting to create patient-specific implants and tissues, tailored to individual anatomies and needs. Imagine a custom-made cartilage implant, perfectly fitted to a patient's damaged knee, restoring mobility and comfort. Bioprinted skin grafts heal severe burns and wounds, restoring not only physical integrity but also emotional well-being. Picture a bioprinted skin patch, seamlessly integrating with a patient's own tissue, minimizing scarring and infection. In the realm of cosmetics, bioprinted skin models replace animal testing, ensuring ethical and effective product development. Envision a laboratory where skin cells are printed to test the safety and efficacy of new skincare formulations. The food industry explores bioprinted meat and other food products, addressing sustainability and nutritional needs. Imagine a future where steak is cultivated from cells, reducing the environmental impact of traditional agriculture. Dental applications include bioprinted dental implants and scaffolds, restoring smiles and oral health. Picture a dentist's office where custom-made dental implants are printed on demand, eliminating long waiting times and multiple appointments. Research and development utilize bioprinted models for studying diseases and developing new therapies, unlocking the secrets of human biology. Envision a research lab where bioprinted vascular networks are used to study angiogenesis and develop treatments for cardiovascular diseases. The application segment is a testament to the transformative potential of 3D bioprinting, where innovation meets compassion, and scientific breakthroughs translate into real-world solutions.

The end-user segment of the 3D bioprinting market is a diverse ecosystem, each player contributing to the advancement and application of this transformative technology. Picture a dynamic network of interconnected entities, each playing a vital role in the journey from research to patient care. Hospitals and clinics are at the forefront, utilizing bioprinted tissues and organs for transplantation and regenerative therapies. Imagine a surgical suite where a bioprinted skin graft is seamlessly applied to a burn victim, or a transplant center where a bioprinted kidney offers a lifeline to a patient in need. Pharmaceutical and biotechnology companies leverage bioprinted models for drug discovery and development, accelerating the pace of innovation. Envision a research lab where a pharmaceutical company tests a new cancer drug on a bioprinted tumor, gaining valuable insights before human trials. Academic and research institutions drive fundamental research and development, pushing the boundaries of bioprinting technology. Picture a university lab where researchers are developing novel bioinks and bioprinting techniques, laying the foundation for future breakthroughs. Medical device companies integrate bioprinting into their product lines, offering innovative solutions for personalized medicine and patient care. Imagine a medical device manufacturer producing custom-made orthopedic implants using bioprinting technology. Cosmetic companies utilize bioprinted skin models for ethical and effective product testing, ensuring consumer safety and satisfaction. Envision a cosmetics lab where a company tests a new skincare product on a bioprinted skin model, avoiding animal testing. Food companies explore bioprinted food products, addressing sustainability and nutritional needs. Imagine a food processing plant where cultured meat is produced using bioprinting technology. Government agencies and regulatory bodies play a crucial role in funding research, establishing standards, and ensuring the safety and efficacy of bioprinted products. Picture a government agency funding a research project to develop bioprinted organs, or a regulatory body establishing guidelines for the clinical use of bioprinted tissues. Each end-user, from the surgeon to the researcher, contributes to the vibrant and evolving landscape of 3D bioprinting.

The regional landscape of the 3D bioprinting market is a tapestry of diverse ecosystems, each fostering innovation and adoption in its unique way. Picture a global map, where hotspots of bioprinting activity illuminate the world. North America, with its robust research infrastructure and strong funding support, leads the charge in technological development and clinical translation. Envision a cluster of research institutions and biotech companies in Boston, pioneering new bioprinting techniques and therapies. Europe, with its focus on collaboration and regulatory harmonization, fosters a thriving ecosystem of academic and industrial innovation. Picture a network of research centers and hospitals across Europe, collaborating on projects to develop bioprinted organs and tissues. Asia-Pacific, with its rapidly growing healthcare sector and increasing investments in research and development, is emerging as a major player in the market. Envision a hub of bioprinting activity in Singapore, where research institutions and companies are collaborating to develop innovative bioprinting solutions. Latin America, with its growing healthcare needs and increasing access to advanced technologies, is gradually adopting bioprinting for various applications. Picture a hospital in Brazil using bioprinted skin grafts to treat burn victims. The Middle East and Africa, with their focus on improving healthcare infrastructure and addressing unmet medical needs, are exploring the potential of bioprinting. Picture a research center in Saudi Arabia investigating the use of bioprinting for tissue engineering. Each region, with its unique strengths and challenges, contributes to the global growth and evolution of the 3D bioprinting market. The distribution of research funding, regulatory frameworks, and healthcare infrastructure varies across regions, influencing the pace and direction of bioprinting adoption.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval

Table of Contents

  • 1 Introduction 10
  • 1.1 Industry Definition and Research Scope 10
  • 1.1.1 Industry Definition 10
  • 1.1.2 Research Scope 11
  • 1.2 Research Methodology 14
  • 1.2.1 Overview of Market Research Methodology 14
  • 1.2.2 Market Assumption 15
  • 1.2.3 Secondary Data 15
  • 1.2.4 Primary Data 15
  • 1.2.5 Data Filtration and Model Design 16
  • 1.2.6 Market Size/Share Estimation 17
  • 1.2.7 Research Limitations 18
  • 1.3 Executive Summary 19
  • 2 Market Overview and Dynamics 22
  • 2.1 Market Size and Forecast 22
  • 2.1.1 Impact of COVID-19 on World Economy 23
  • 2.1.2 Impact of COVID-19 on the Market 27
  • 2.2 Major Growth Drivers 29
  • 2.3 Market Restraints and Challenges 35
  • 2.4 Emerging Opportunities and Market Trends 38
  • 2.5 Porter’s Fiver Forces Analysis 42
  • 3 Segmentation of Global Market by Component 46
  • 3.1 Market Overview by Component 46
  • 3.2 3D Bioprinters 48
  • 3.3 Bioinks 51
  • 4 Segmentation of Global Market by Material 53
  • 4.1 Market Overview by Material 53
  • 4.2 Living Cells 55
  • 4.3 Hydrogels 56
  • 4.4 Extracellular Matrices 57
  • 4.5 Other Material Types 58
  • 5 Segmentation of Global Market by Technology 59
  • 5.1 Market Overview by Technology 59
  • 5.2 Inkjet 3D Bioprinting 61
  • 5.3 Laser-assisted Bioprinting 62
  • 5.4 Magnetic 3D Bioprinting 63
  • 5.5 Microextrusion Bioprinting 64
  • 5.6 Other Technologies 65
  • 6 Segmentation of Global Market by Application 66
  • 6.1 Market Overview by Application 66
  • 6.2 Research Application 68
  • 6.2.1 Drug Research 69
  • 6.2.2 Regenerative Medicine 70
  • 6.2.3 3D Cell Culture 71
  • 6.3 Clinical Application 72
  • 6.3.1 Skin 73
  • 6.3.2 Bone and Cartilage 74
  • 6.3.3 Blood Vessels 75
  • 6.3.4 Other Clinical Applications 76
  • 7 Segmentation of Global Market by End User 77
  • 7.1 Market Overview by End User 77
  • 7.2 Research Organization & Academic Institutes 79
  • 7.3 Biopharmaceutical Companies 80
  • 7.4 Hospitals 81
  • 7.5 Other End Users 82
  • 8 Segmentation of Global Market by Region 83
  • 8.1 Geographic Market Overview 2021-2031 83
  • 8.2 North America Market 2021-2031 by Country 87
  • 8.2.1 Overview of North America Market 87
  • 8.2.2 U.S. 91
  • 8.2.3 Canada 94
  • 8.2.4 Mexico 96
  • 8.3 European Market 2021-2031 by Country 98
  • 8.3.1 Overview of European Market 98
  • 8.3.2 Germany 102
  • 8.3.3 U.K. 104
  • 8.3.4 France 106
  • 8.3.5 Spain 108
  • 8.3.6 Italy 110
  • 8.3.7 Netherlands 112
  • 8.3.8 Rest of European Market 114
  • 8.4 Asia-Pacific Market 2021-2031 by Country 116
  • 8.4.1 Overview of Asia-Pacific Market 116
  • 8.4.2 Japan 120
  • 8.4.3 China 123
  • 8.4.4 Australia 125
  • 8.4.5 India 127
  • 8.4.6 South Korea 129
  • 8.4.7 Rest of APAC Region 131
  • 8.5 South America Market 2021-2031 by Country 133
  • 8.5.1 Argentina 136
  • 8.5.2 Brazil 138
  • 8.5.3 Chile 140
  • 8.5.4 Rest of South America Market 142
  • 8.6 MEA Market 2021-2031 by Country 143
  • 8.6.1 UAE 146
  • 8.6.2 Saudi Arabia 148
  • 8.6.3 South Africa 150
  • 8.6.4 Other National Markets 152
  • 9 Competitive Landscape 153
  • 9.1 Overview of Key Vendors 153
  • 9.2 New Product Launch, Partnership, Investment, and M&A 156
  • 9.3 Company Profiles 157
  • 3D Bio-printing Solutions 157
  • 3D Systems Inc. 159
  • 3DBio Therapeutics 160
  • Advanced Solutions Life Sciences LLC (ASI) 161
  • Aspect Biosystems Ltd. 162
  • Bico Group AB 163
  • Brinter 164
  • Cellink AB 165
  • CollPlant Biotechnologies Ltd. 166
  • Cyfuse Biomedical K. K. 167
  • Digilab Inc. 168
  • EnvisionTEC GmbH (Desktop Metal Inc.) 169
  • Foldink Life Science Technologies 170
  • GeSiM – Gesellschaft für Silizium-Mikrosysteme mbH 171
  • Inventia Life Science Pty Ltd. 172
  • Nano3D Biosciences Inc. 173
  • Organovo Holdings Inc 174
  • Pandorum Technologies Pvt. Ltd. 175
  • Poietis 176
  • Precise Bio 177
  • Prellis Biologics 178
  • Regemat 3D S.L. 179
  • RegenHU SA 180
  • Regenovo Biotechnology Co. Ltd. (Part of Shining 3D Tech Co., Ltd.) 181
  • ROKIT Healthcare, INC. 182
  • Stratasys Ltd. 183
  • TeVido BioDevices, Inc. 184
  • Vivax Bio, LLC 185
  • RELATED REPORTS 186

List of Figures:

Figure 1. Research Method Flow Chart 14
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 17
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 19
Figure 4. Global 3D Bioprinting Market, 2021-2031, $ mn 22
Figure 5. Impact of COVID-19 on Business 27
Figure 6. Primary Drivers and Impact Factors of Global 3D Bioprinting Market 29
Figure 7. Total Global Regenerative Medicine Financing, 2018-2021 1H, $ mn 32
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 33
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060 33
Figure 10. Primary Restraints and Impact Factors of Global 3D Bioprinting Market 35
Figure 11. Investment Opportunity Analysis 39
Figure 12. Porter’s Fiver Forces Analysis of Global 3D Bioprinting Market 42
Figure 13. Breakdown of Global 3D Bioprinting Market by Component, 2021-2031, % of Revenue 47
Figure 14. Global Addressable Market Cap in 2022-2031 by Component, Value ($ mn) and Share (%) 47
Figure 15. Global 3D Bioprinting Market by Component: 3D Bioprinters, 2021-2031, $ mn 48
Figure 16. Global 3D Bioprinting Market by Component: Bioinks, 2021-2031, $ mn 51
Figure 17. Breakdown of Global 3D Bioprinting Market by Material, 2021-2031, % of Sales Revenue 54
Figure 18. Global Addressable Market Cap in 2022-2031 by Material, Value ($ mn) and Share (%) 54
Figure 19. Global 3D Bioprinting Market by Material: Living Cells, 2021-2031, $ mn 55
Figure 20. Global 3D Bioprinting Market by Material: Hydrogels, 2021-2031, $ mn 56
Figure 21. Global 3D Bioprinting Market by Material: Extracellular Matrices, 2021-2031, $ mn 57
Figure 22. Global 3D Bioprinting Market by Material: Other Material Types, 2021-2031, $ mn 58
Figure 23. Breakdown of Global 3D Bioprinting Market by Technology, 2021-2031, % of Sales Revenue 60
Figure 24. Global Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%) 60
Figure 25. Global 3D Bioprinting Market by Technology: Inkjet 3D Bioprinting, 2021-2031, $ mn 61
Figure 26. Global 3D Bioprinting Market by Technology: Laser-assisted Bioprinting, 2021-2031, $ mn 62
Figure 27. Global 3D Bioprinting Market by Technology: Magnetic 3D Bioprinting, 2021-2031, $ mn 63
Figure 28. Global 3D Bioprinting Market by Technology: Microextrusion Bioprinting, 2021-2031, $ mn 64
Figure 29. Global 3D Bioprinting Market by Technology: Other Technologies, 2021-2031, $ mn 65
Figure 30. Breakdown of Global 3D Bioprinting Market by Application, 2021-2031, % of Revenue 67
Figure 31. Global Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 67
Figure 32. Global 3D Bioprinting Market by Application: Research Application, 2021-2031, $ mn 68
Figure 33. Global 3D Bioprinting Market by Research Application: Drug Research, 2021-2031, $ mn 69
Figure 34. Global 3D Bioprinting Market by Research Application: Regenerative Medicine, 2021-2031, $ mn 70
Figure 35. Global 3D Bioprinting Market by Research Application: 3D Cell Culture, 2021-2031, $ mn 71
Figure 36. Global 3D Bioprinting Market by Application: Clinical Application, 2021-2031, $ mn 72
Figure 37. Global 3D Bioprinting Market by Clinical Application: Skin, 2021-2031, $ mn 73
Figure 38. Global 3D Bioprinting Market by Clinical Application: Bone and Cartilage, 2021-2031, $ mn 74
Figure 39. Global 3D Bioprinting Market by Clinical Application: Blood Vessels, 2021-2031, $ mn 75
Figure 40. Global 3D Bioprinting Market by Clinical Application: Other Clinical Applications, 2021-2031, $ mn 76
Figure 41. Breakdown of Global 3D Bioprinting Market by End User, 2021-2031, % of Revenue 78
Figure 42. Global Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 78
Figure 43. Global 3D Bioprinting Market by End User: Research Organization & Academic Institutes, 2021-2031, $ mn 79
Figure 44. Global 3D Bioprinting Market by End User: Biopharmaceutical Companies, 2021-2031, $ mn 80
Figure 45. Global 3D Bioprinting Market by End User: Hospitals, 2021-2031, $ mn 81
Figure 46. Global 3D Bioprinting Market by End User: Other End Users, 2021-2031, $ mn 82
Figure 47. Global Market Snapshot by Region 83
Figure 48. Geographic Spread of Worldwide 3D Bioprinting Market, 2021-2031, % of Sales Revenue 84
Figure 49. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%) 85
Figure 50. North American 3D Bioprinting Market, 2021-2031, $ mn 88
Figure 51. Breakdown of North America 3D Bioprinting Market by Country, 2021 and 2031, % of Revenue 89
Figure 52. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 90
Figure 53. U.S. 3D Bioprinting Market, 2021-2031, $ mn 92
Figure 54. Canada 3D Bioprinting Market, 2021-2031, $ mn 94
Figure 55. 3D Bioprinting Market in Mexico, 2021-2031, $ mn 96
Figure 56. European 3D Bioprinting Market, 2021-2031, $ mn 99
Figure 57. Breakdown of European 3D Bioprinting Market by Country, 2021 and 2031, % of Revenue 100
Figure 58. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 101
Figure 59. 3D Bioprinting Market in Germany, 2021-2031, $ mn 102
Figure 60. 3D Bioprinting Market in U.K., 2021-2031, $ mn 104
Figure 61. 3D Bioprinting Market in France, 2021-2031, $ mn 106
Figure 62. 3D Bioprinting Market in Spain, 2021-2031, $ mn 108
Figure 63. 3D Bioprinting Market in Italy, 2021-2031, $ mn 110
Figure 64. 3D Bioprinting Market in Netherlands, 2021-2031, $ mn 112
Figure 65. 3D Bioprinting Market in Rest of Europe, 2021-2031, $ mn 114
Figure 66. Asia-Pacific 3D Bioprinting Market, 2021-2031, $ mn 117
Figure 67. Breakdown of APAC 3D Bioprinting Market by Country, 2021 and 2031, % of Revenue 117
Figure 68. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 119
Figure 69. 3D Bioprinting Market in Japan, 2021-2031, $ mn 121
Figure 70. 3D Bioprinting Market in China, 2021-2031, $ mn 123
Figure 71. 3D Bioprinting Market in Australia, 2021-2031, $ mn 125
Figure 72. 3D Bioprinting Market in India, 2021-2031, $ mn 127
Figure 73. 3D Bioprinting Market in South Korea, 2021-2031, $ mn 129
Figure 74. 3D Bioprinting Market in Rest of APAC, 2021-2031, $ mn 131
Figure 75. South America 3D Bioprinting Market, 2021-2031, $ mn 134
Figure 76. Breakdown of South America 3D Bioprinting Market by Country, 2021 and 2031, % of Revenue 134
Figure 77. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 135
Figure 78. 3D Bioprinting Market in Argentina, 2021-2031, $ mn 136
Figure 79. 3D Bioprinting Market in Brazil, 2021-2031, $ mn 138
Figure 80. 3D Bioprinting Market in Chile, 2021-2031, $ mn 140
Figure 81. 3D Bioprinting Market in Rest of South America, 2021-2031, $ mn 142
Figure 82. 3D Bioprinting Market in Middle East and Africa (MEA), 2021-2031, $ mn 144
Figure 83. Breakdown of MEA 3D Bioprinting Market by Country, 2021 and 2031, % of Revenue 144
Figure 84. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 145
Figure 85. 3D Bioprinting Market in UAE, 2021-2031, $ mn 146
Figure 86. 3D Bioprinting Market in Saudi Arabia, 2021-2031, $ mn 148
Figure 87. 3D Bioprinting Market in South Africa, 2021-2031, $ mn 150
Figure 88. Growth Stage of Global 3D Bioprinting Industry over the Forecast Period 153

List of Tables:

Table 1. Snapshot of Global 3D Bioprinting Market in Balanced Perspective, 2021-2031 20
Table 2. World Economic Outlook, 2021-2031 24
Table 3. World Economic Outlook, 2021-2023 25
Table 4. World Health Spending by Region, $ bn, 2013-2020 34
Table 5. Main Product Trends and Market Opportunities in Global 3D Bioprinting Market 38
Table 6. Global 3D Bioprinting Market by Component, 2021-2031, $ mn 46
Table 7. Main Vendors and 3D Bioprinters on Market 49
Table 8. Comparison of Types of Bioprinters 50
Table 9. Global 3D Bioprinting Market: Bioinks by Type, 2021-2031, $ mn 51
Table 10. Main Vendors and 3D Bioinks on Market 52
Table 11. Global 3D Bioprinting Market by Material, 2021-2031, $ mn 53
Table 12. Global 3D Bioprinting Market by Technology, 2021-2031, $ mn 59
Table 13. Global 3D Bioprinting Market by Application, 2021-2031, $ mn 66
Table 14. Global 3D Bioprinting Market: Research Application by Type, 2021-2031, $ mn 68
Table 15. Global 3D Bioprinting Market: Clinical Application by Type, 2021-2031, $ mn 72
Table 16. Global 3D Bioprinting Market by End User, 2021-2031, $ mn 77
Table 17. Global 3D Bioprinting Market by Region, 2021-2031, $ mn 84
Table 18. Leading National 3D Bioprinting Market, 2021 and 2031, $ mn 86
Table 19. North America 3D Bioprinting Market by Country, 2021-2031, $ mn 89
Table 20. U.S. 3D Bioprinting Market by Component, 2021-2031, $ mn 93
Table 21. U.S. 3D Bioprinting Market by Material, 2021-2031, $ mn 93
Table 22. U.S. 3D Bioprinting Market by Application, 2021-2031, $ mn 93
Table 23. Canada 3D Bioprinting Market by Component, 2021-2031, $ mn 95
Table 24. Canada 3D Bioprinting Market by Material, 2021-2031, $ mn 95
Table 25. Canada 3D Bioprinting Market by Application, 2021-2031, $ mn 95
Table 26. Mexico 3D Bioprinting Market by Component, 2021-2031, $ mn 97
Table 27. Mexico 3D Bioprinting Market by Material, 2021-2031, $ mn 97
Table 28. Mexico 3D Bioprinting Market by Application, 2021-2031, $ mn 97
Table 29. Europe 3D Bioprinting Market by Country, 2021-2031, $ mn 101
Table 30. Germany 3D Bioprinting Market by Component, 2021-2031, $ mn 103
Table 31. Germany 3D Bioprinting Market by Material, 2021-2031, $ mn 103
Table 32. Germany 3D Bioprinting Market by Application, 2021-2031, $ mn 103
Table 33. U.K. 3D Bioprinting Market by Component, 2021-2031, $ mn 105
Table 34. U.K. 3D Bioprinting Market by Material, 2021-2031, $ mn 105
Table 35. U.K. 3D Bioprinting Market by Application, 2021-2031, $ mn 105
Table 36. France 3D Bioprinting Market by Component, 2021-2031, $ mn 107
Table 37. France 3D Bioprinting Market by Material, 2021-2031, $ mn 107
Table 38. France 3D Bioprinting Market by Application, 2021-2031, $ mn 107
Table 39. Spain 3D Bioprinting Market by Component, 2021-2031, $ mn 109
Table 40. Spain 3D Bioprinting Market by Material, 2021-2031, $ mn 109
Table 41. Spain 3D Bioprinting Market by Application, 2021-2031, $ mn 109
Table 42. Italy 3D Bioprinting Market by Component, 2021-2031, $ mn 111
Table 43. Italy 3D Bioprinting Market by Material, 2021-2031, $ mn 111
Table 44. Italy 3D Bioprinting Market by Application, 2021-2031, $ mn 111
Table 45. Netherlands 3D Bioprinting Market by Component, 2021-2031, $ mn 113
Table 46. Netherlands 3D Bioprinting Market by Material, 2021-2031, $ mn 113
Table 47. Netherlands 3D Bioprinting Market by Application, 2021-2031, $ mn 113
Table 48. 3D Bioprinting Market in Rest of Europe by Country, 2021-2031, $ mn 115
Table 49. APAC 3D Bioprinting Market by Country, 2021-2031, $ mn 118
Table 50. Japan 3D Bioprinting Market by Component, 2021-2031, $ mn 122
Table 51. Japan 3D Bioprinting Market by Material, 2021-2031, $ mn 122
Table 52. Japan 3D Bioprinting Market by Application, 2021-2031, $ mn 122
Table 53. China 3D Bioprinting Market by Component, 2021-2031, $ mn 124
Table 54. China 3D Bioprinting Market by Material, 2021-2031, $ mn 124
Table 55. China 3D Bioprinting Market by Application, 2021-2031, $ mn 124
Table 56. Australia 3D Bioprinting Market by Component, 2021-2031, $ mn 126
Table 57. Australia 3D Bioprinting Market by Material, 2021-2031, $ mn 126
Table 58. Australia 3D Bioprinting Market by Application, 2021-2031, $ mn 126
Table 59. India 3D Bioprinting Market by Component, 2021-2031, $ mn 128
Table 60. India 3D Bioprinting Market by Material, 2021-2031, $ mn 128
Table 61. India 3D Bioprinting Market by Application, 2021-2031, $ mn 128
Table 62. South Korea 3D Bioprinting Market by Component, 2021-2031, $ mn 130
Table 63. South Korea 3D Bioprinting Market by Material, 2021-2031, $ mn 130
Table 64. South Korea 3D Bioprinting Market by Application, 2021-2031, $ mn 130
Table 65. 3D Bioprinting Market in Rest of APAC by Country/Region, 2021-2031, $ mn 132
Table 66. South America 3D Bioprinting Market by Country, 2021-2031, $ mn 135
Table 67. Argentina 3D Bioprinting Market by Component, 2021-2031, $ mn 137
Table 68. Argentina 3D Bioprinting Market by Material, 2021-2031, $ mn 137
Table 69. Argentina 3D Bioprinting Market by Application, 2021-2031, $ mn 137
Table 70. Brazil 3D Bioprinting Market by Component, 2021-2031, $ mn 139
Table 71. Brazil 3D Bioprinting Market by Material, 2021-2031, $ mn 139
Table 72. Brazil 3D Bioprinting Market by Application, 2021-2031, $ mn 139
Table 73. Chile 3D Bioprinting Market by Component, 2021-2031, $ mn 141
Table 74. Chile 3D Bioprinting Market by Material, 2021-2031, $ mn 141
Table 75. Chile 3D Bioprinting Market by Application, 2021-2031, $ mn 141
Table 76. MEA 3D Bioprinting Market by Country, 2021-2031, $ mn 145
Table 77. UAE 3D Bioprinting Market by Component, 2021-2031, $ mn 147
Table 78. UAE 3D Bioprinting Market by Material, 2021-2031, $ mn 147
Table 79. UAE 3D Bioprinting Market by Application, 2021-2031, $ mn 147
Table 80. Saudi Arabia 3D Bioprinting Market by Component, 2021-2031, $ mn 149
Table 81. Saudi Arabia 3D Bioprinting Market by Material, 2021-2031, $ mn 149
Table 82. Saudi Arabia 3D Bioprinting Market by Application, 2021-2031, $ mn 149
Table 83. South Africa 3D Bioprinting Market by Component, 2021-2031, $ mn 151
Table 84. South Africa 3D Bioprinting Market by Material, 2021-2031, $ mn 151
Table 85. South Africa 3D Bioprinting Market by Application, 2021-2031, $ mn 151
Table 86. 3D Bio-printing Solutions: Company Snapshot 157
Table 87. 3D Bio-printing Solutions: Business Segmentation 158
Table 88. 3D Bio-printing Solutions: Product Portfolio 158
Logo

Global 3D Bioprinting Market Outlook, 2030

Contact usWe are friendly and approachable, give us a call.